BioLargo Presentation for Rodman Renshaw

1. Forward Looking Statements
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results
to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current
and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December
31, 2015.
Science & Technology
Water – Air – Food – Plants – Animals –
People
Making them Clean Safe & Healthy
Impacting the World

2. About biolargo
2
Industrial & consumer products
Water disinfection / dosing
Water disinfection & decontamination
Wound care & disinfection

3. Recent Highlights
 Industrial Odor Control- Wins Key Accounts and
Sales and Manufacturing Ramping
 AOS Filter is Lowest Cost & Highest Impact Clean
Water Technology- Innovation Leader – First
Commercial Prototype Delivered August 2016
 Wound Care – Funded –Targeting 2017 FDA 510k -
 Isan Dosing System EPA approved summer 2016
3

4. BIOLARGO’s AOS FILTER
Converts a filter into a powerful reactor to
manage and remove harmful contaminants
4
A SCALABLE WATER TECHNOLOGY

5. AOS Impact may Extend to Every Segment of the
$360 billion Global Water Industry
5

6. AOS - Targeting high-value needs
6
Pick a lane to WIN!

7. The BioLargo Advanced
Oxidation System (AOS) Filter
HOW IT WORKS
7
“Unprecedented Results”
*Professor Lynn McMullen, University of Alberta
Carbon Iodine Chemistry Electricity *Extremely High
Oxidation Potential

8. UniqueValue proposition
When compared to all known competing technologies,
BioLargo’s AOS filter has been proven in hundreds of lab
tests at the University of Alberta to be:
8
 up to 100x more effective
 1/20th
the cost
 10x faster

9. History of Research Collaborations
9

10. Assets built to license:
Advanced wound care
 Financing Secured
 Proof of Efficacy Accomplished
 Pathway to Success is clear for $1B+ opportunity
– 510k pathway – experts contracted & underway
Manufacturing, Formulation, Packaging, Labeling, Regulatory
 Proven Leadership Team
 Liquids, Hydrogels & Dressings
 High Profit Margins
10

11. Cupridyne clean
Industrial Odor Control
11
Unprecedented performance
Large highly fragmented
industry
Dissatisfied with old products
Odor control a top priority
Free trial & satisfaction
guarantee
Sales network activating
Key accounts LOVE IT!

12. Poultry Biosecurity Solutions
Aqueous Iodine Sanitation Systems

13. iSAN® Systems
• Specifications
• Capacity: up to 750 gallons per minute at
recommended poultry dosing levels.
• Ability to capture all sanitation byproducts
through proprietary anion exchange capture
resin system.
• Full data logging and audit capability.
• 24x7 remote monitoring.
• User-friendly, touch screen HMI.
• Can be enclosed or unenclosed.

14. Key benchmarks ahead
 AOS market-ready pilots targeting early 2017
 Successful Commercial Scale Pilots
 Expanded Grants / Collaborations
 Establish strategic partnerships
 New capital is required for product development,
manufacturing and launch products
 Expand Existing Orders
 First AOS Commercial Sales
 Fortify the Management Team
 Extend Marketing and Sales
 Target Up-List to NASDAQ
14

15. Company Contact:
Dennis Calvert
President & CEO
BioLargo, Inc.
(949) 643-9540
dc@biolargo.com
www.biolargo.com